Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Theralink Technologies
Golden, Colorado, United Statesthera-link.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Commercial
01
Overview
Theralink commercialized a CLIA-certified laboratory-developed test for advanced breast cancer that uses proteomic profiling to guide targeted therapy selection. A second pan-tumor solid tumor assay was under development at the time of asset acquisition. The company’s platform provided actionable data to oncologists and biopharma partners regarding likely responders/nonresponders to FDA-approved or investigational drugs
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic assayLaboratory developed test (LDT)Proteomics-based assay
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Theralink Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theralink Technologies.